Stocks could continue to shake off recent weak data Wednesday, as Apple unveils new iPhone 7 and two Fed officials are on the hot seat before Congress.
Check out the companies making headlines after the bell Tuesday: Chipotle, Dave & Buster's, Advanced Micro Devices and more.
Russian President Vladimir Putin's seemingly cozy talks with Saudi Arabia may put a floor under oil, possibly limiting what could have been a sharp drop later this month.
Stocks that would do well in the event of a GOP presidential victory are no longer lagging the Clinton stocks as much as they had been.
"CEOs should be kept around a long time if they perform well, and not if they don't," says CLSA's Mike Mayo.
Lots of ETFs are on the dividend yield bandwagon, but only one claims it can predict which stocks will boost payouts.
Those who think the Fed should be raising rates aren't getting a lot of help from the data on which the central bank professes to be so dependent.
Morgan Stanley increased its 12-month price target for the S&P 500, noting that U.S. equities remain the best place to be for investors.
After a plunge in manufacturing activity, the much bigger services sector showed a surprise massive slowing in growth in August, raising new warnings on the economy.
Gilead Sciences rose Tuesday after it was upgraded, citing confidence in the prospects for Gilead's HIV treatments among other factors.
Goldman Sachs economists believe Fed officials were intentionally sending a strong signal about raising rates in September.
Some of the names on the move ahead of the open.
If there was any question whether the Fed would hold off on hiking interest rates, Friday's jobs report may have put it to rest.
Trump said that the Fed is keeping interest rates low to prevent an economic downturn and "at some point" the rates must change.
The market for non-performing loans is growing and is slowly establishing itself, Nicola Rossi, president of Banca Popolare di Milano, told CNBC on Saturday
With not much on the calendar, market focus will move to the price of oil, a few economic reports and whatever the winds blow in from overseas.
If investors looked just at the broad stock market's slow grind, they'd have missed opportunities in some recently shunned sectors.
Shares of Mylan extended losses Friday after claims that Mylan misclassified the lifesaving EpiPen device.
Now that the August jobs report is in, major Wall Street firms are mostly looking at a rate hike in December at the earliest.
Shares of firearms companies sold off Friday, after August data on national gun background checks showed a slowdown from the recent surge.
Get the best of CNBC in your inbox